Access to Essential Medicines for Rheumatic Dis...

By HEOR Staff Writer

July 19, 2024

Introduction The Global Burden of Disease (GBD) study has highlighted the increasing prevalence of musculoskeletal disorders in Africa, significantly affecting children and young people (CYP). ...
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Unlocking the Potential of Cell and Gene Therapies: A Path to Affordable Heal...
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Managing Access to Medicines in the Future: Innovations and Strategies
Economics in Clinical Trials: A Guide to Value-Based Decisions
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
Evaluating the Cost-Effectiveness of Adebrelimab in ES-SCLC